HWHeng Wan

Heng Wan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Heng Wan has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Shen

    The Eighth Affiliated Hospital, Southern Medical University (The First People’s Hospital of Shunde, Foshan), China

    21 shared publications
  • Genfeng Yu

    Department of Endocrinology and Metabolism The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde) Foshan Guangdong China

    16 shared publications
  • Lan Liu

    Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People’s Hospital of Shunde), Foshan, China

    13 shared publications
  • Siyang Liu

    Department of Endocrinology and Metabolism The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde) Foshan China

    13 shared publications
  • Hualin Duan

    Department of Endocrinology and Metabolism The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde) Foshan China

    12 shared publications
  • Dongmei Wang

    Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People’s Hospital of Shunde), Foshan, Guangdong, People’s Republic of China

    11 shared publications

Latest Publications

  • Open Access

    Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in individuals with MASLD

    by Yijun Lin, Qianyun Wang, Ying Sun, Yuefeng Yu, Yingwen Nie, Keyue Yang, Ningjian Wang, Heng Wan, Feng Tian

    Background: The impact of clonal haematopoiesis of indeterminate potential (CHIP), a novel cardiovascular risk factor, remains unclear in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), where cardiovascular disease (CVD) is the main cause of mortality. Methods: We analysed data from 140,086 UK Biobank participants with MASLD. CHIP was identified via whole-exome sequencing. Incident CVD, including coronary heart disease (CHD), stroke, and heart failure (HF), was the primary outcome. Cox proportional hazards models assessed the association between CHIP and CVD risk. Results: During a median 13.5-year follow-up, 15.7% of participants developed CVD. CHIP was associated with a higher risk of CVD (HR: 1.16, 95% CI: 1.09–1.23), with higher risks of stroke (HR: 1.22, 95% CI: 1.07–1.38) and HF (HR: 1.34, 95% CI: 1.21–1.49). Mutations in ASXL1, SRSF2, JAK2 , and SF3B1 were associated with a particularly high CVD risk. Additionally, a higher clonal haematopoiesis risk score (CHRS) was associated with incident CVD, CHD, stroke, and HF. In the three-category analysis, the P value for trend was significant for all outcomes, but the association was confined to large CHIP for CVD and CHD, whereas both CHIP categories showed elevated estimates for stroke and HF. Conclusions: CHIP is independently associated with incident CVD in patients with MASLD. These findings support prospective evaluation of CHIP-informed cardiovascular risk stratification in this population.

  • Open Access

    Associations of grip strength, muscle mass, and fat-to-muscle ratio with advanced cardiovascular-kidney-metabolic syndrome in chinese community adults

    by Shidi Hu, Hong Ye, Zhi Chen, Yi Zeng, Junjie Yang, Yuan Meng, Xuetao Peng, Lan Liu, Heng Wan, Jie Shen, et al.

  • Associations Between Domestic Water Hardness, Genetic Risk and Severe MASLD : A Large‐Scale Cohort Study

    by Xiaoyu Zhao, Zihao Gui, Houde He, Mengyuan Yang, Yijun Lin, Jie Shen, Ningjian Wang, Heng Wan, Feng Tian

    This study aims to investigate the association between domestic water hardness and the risk of severe metabolic dysfunction‐associated steatotic liver disease (MASLD) and to assess the potential modifying role of genetic susceptibility. The UK Biobank is a prospective cohort study that recruited over 500,000 participants across the United Kingdom between 2006 and 2010. Domestic water hardness was assessed based on calcium carbonate (CaCO 3 ) concentration. Severe MASLD was defined using ICD‐10 codes and death registry data. A polygenic risk score (PRS) for severe MASLD was constructed using 61 single nucleotide polymorphisms (SNPs) and divided into tertiles (low, intermediate, high risk). Cox proportional hazards regression models and restricted cubic spline analyses were employed. A total of 7039 incident severe MASLD cases (1.5%) were documented during a mean 13.8‐year follow‐up. Compared to water hardness < 100 mg/L, individuals with domestic water hardness of 100–200 mg/L were associated with a 22% lower risk of severe MASLD (HR 0.78, 95% CI 0.72–0.86), while water hardness > 200 mg/L was associated with an 11% higher risk (HR 1.11, 95% CI 1.05–1.16). A non‐linear relationship was observed between water hardness and severe MASLD incidence ( p for non‐linear < 0.001). The association did not significantly differ across strata of genetic susceptibility ( p ‐interaction > 0.05). The study revealed a U ‐shaped relationship between water hardness and severe MASLD, which was robust to genetic risk. An optimal water hardness range (100–200 mg/L) may serve as a modifiable environmental factor for the prevention of severe MASLD.

  • Changes in Muscle Mass and the Risk of Liver‐Related Events: A Prospective Cohort Study

    by Zihao Gui, Hualin Duan, Qingtao Yu, Junnian Chen, Huanyi Cao, Siyang Liu, Lan Liu, Jie Shen, Heng Wan

    Background and Aims: Previous studies found that lower muscle mass at baseline was an important risk factor for liver‐related events (LRE), yet evidence on longitudinal muscle mass changes remains limited. This study examines associations between changes in muscle mass and incident LRE. Methods: This prospective cohort study included 19 660 participants with baseline and first follow‐up body composition data. Appendicular skeletal muscle mass (ASM) was estimated using bioelectrical impedance analysis and the Janssen equation, and was indexed to body mass index as ASM/BMI. ΔASM/BMI was calculated as ASM/BMI at first follow‐up minus ASM/BMI at baseline. Follow‐up for incident LRE started at the first follow‐up assessment. Cox proportional hazards models, restricted cubic spline analyses, subgroup analyses, competing‐risk models, and sensitivity analyses were performed. Results: During a median follow‐up of 9.87 years, 101 incident LRE were identified. In the fully adjusted model, higher ΔASM/BMI was associated with a lower risk of incident LRE. Compared with participants in the lowest tertile, those in the intermediate and highest tertiles had lower LRE risk, with HRs of 0.59 (95% CI, 0.37–0.94) and 0.44 (95% CI, 0.27–0.72), respectively. The association was more pronounced among participants younger than 60 years ( p for interaction = 0.042). Restricted cubic spline analysis showed a significant nonlinear association between ΔASM/BMI and LRE risk (P‐overall = 0.012; p ‐non‐linear = 0.029). Results were generally consistent in competing‐risk, sensitivity, propensity score‐based, and nested case–control analyses. Conclusion: Greater preservation or increase in muscle mass was associated with a lower risk of incident LRE, particularly among participants younger than 60 years. These findings support the potential relevance of maintaining muscle mass for liver risk stratification.

  • Longitudinal changes in fatty liver index, genetic susceptibility, and incident atrial fibrillation

    by Siyang Liu, Houde He, Hualan Chen, Hualin Duan, Ying Sun, Dan Deng, Zihao Gui, Lan Liu, Ningjian Wang, Jie Shen, et al.

  • Open Access

    Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis are Associated with Advanced Cardiovascular-Kidney-Metabolic Syndrome in Chinese and US Populations

    by Shidi Hu, Dongmei Wang, Qingtao Yu, Zhi Chen, Weiguo Lu, Yuan Meng, Xuetao Peng, Lan Liu, Heng Wan, Jie Shen

    Purpose: Despite the pathophysiologic overlap between metabolic dysfunction-associated steatotic liver disease (MASLD) and cardiovascular-kidney-metabolic (CKM) syndrome, MASLD has not been incorporated into the current CKM framework. This study examined the associations of MASLD and MASLD-related fibrosis with advanced CKM syndrome in Chinese and US populations. Patients and Methods: We enrolled 6186 participants in a community-based cross-sectional study conducted in China, with validation utilizing the National Health and Nutrition Examination Survey (NHANES). Advanced CKM syndrome was defined as stages 3 and 4. Hepatic steatosis and fibrosis were assessed via vibration-controlled transient elastography. Multivariable logistic regression and restricted cubic spline (RCS) analyses were employed. Results: Advanced CKM syndrome was present in 8.8% of the Chinese and 14.9% of the US populations. MASLD participants exhibited a significantly higher prevalence of advanced CKM than those without (China: 12.6% vs 6.4%; US: 21.5% vs 9.9%). In addition, participants with MASLD were associated with increased odds of advanced CKM (China: OR 2.06, 95% CI: 1.64– 2.58; US: OR 1.60, 95% CI: 1.22– 2.10; both P < 0.01). Among participants with MASLD, advanced CKM syndrome was more prevalent in participants with fibrosis than without (China: 17.1% vs 11.2%; US: 28.4% vs 20.1%). MASLD-related fibrosis was also independently linked to higher odds of advanced CKM compared to non-fibrotic MASLD (China: OR 1.55, 95% CI: 1.09– 2.18; US: OR 1.44, 95% CI: 1.01– 2.05; both P < 0.05). Furthermore, RCS analysis revealed a positive linear relationship of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) values with the prevalence of advanced CKM syndrome (P non-linear > 0.05). Conclusion: MASLD and MASLD-related fibrosis were significantly associated with a higher prevalence of advanced CKM syndrome, and higher CAP/LSM levels showed linear associations with advanced CKM syndrome in both Chinese and US populations. These findings support evaluating liver health (eg, CAP/LSM) when risk-stratifying CKM syndrome.


  • Open Access

    Peripheral Thyroid Hormone Sensitivity Mediates the Association Between Body Composition and Diabetes in Euthyroid Adults

    by Nanfang Yao, Lan Liu, Yuqi Jiang, Dongmei Wang, Qianyi Lu, Yi Zeng, Genfeng Yu, Qintao Ma, Peiyi Li, Lingling Liu, et al.

    Background: Body composition parameters, including fat‐to‐muscle ratio (FMR) and appendicular skeletal muscle mass (ASM), are closely associated with metabolic diseases. However, the mediating role of peripheral thyroid hormone sensitivity, reflected by the free triiodothyronine‐to‐free thyroxine ratio (FT3/FT4 ratio), in these associations remains unclear in euthyroid individuals. The current study aimed to investigate the associations of FMR and ASM/BMI with diabetes and to explore the potential mediating role of FT3/FT4 ratio in these relationships among euthyroid Chinese adults. Methods: This cross‐sectional study enrolled the participants from 10 communities in Guangdong Province, China, from November 2021 to September 2022. Body composition was measured using bioelectrical impedance analysis (BIA). Diabetes was defined based on fasting plasma glucose, 2‐h postload glucose or glycated haemoglobin (HbA1c). Associations of FMR and ASM adjusted for body mass index (ASM/BMI) with diabetes were assessed using multivariable logistic regression. Structural equation modelling was applied to evaluate the mediating effect of FT3/FT4 ratio. Results: A total of 5089 participants (mean age = 46 years, SD = 12) were included in the final analysis, consisting of 1957 men (38.5%) and 3132 women (61.5%). Participants in the third tertile (T3) of FMR exhibited a 79% higher prevalence of diabetes compared to those in the first tertile (T1) (OR 1.79, 95% CI 1.27–2.54) ( p < 0.05). Conversely, those in the T3 of ASM/BMI had a 56% lower prevalence of diabetes compared to participants in T1 (OR 0.44, 95% CI 0.31–0.64) ( p < 0.05). Restricted cubic spline analysis confirmed linear associations for both FMR and ASM/BMI with diabetes (both p for overall < 0.001; p for non‐linear > 0.05). FT3/FT4 ratio significantly mediated the association between ASM/BMI and diabetes, accounting for 4.6% of the total effect ( p < 0.05), whereas no significant mediation was observed in the FMR–diabetes pathway ( p > 0.05). Conclusions: In euthyroid individuals, higher FMR and lower ASM/BMI were independently associated with increased diabetes prevalence. The inverse relationship between ASM/BMI and diabetes may be partially mediated by FT3/FT4 ratio, highlighting peripheral thyroid hormone sensitivity as a potential mechanistic biomarker linking ASM loss to glycaemic dysregulation in euthyroid individuals.


  • Open Access

    Serum essential elements and muscle health in Chinese adults: a community-based study

    by Hong Ye, Dongmei Wang, Siyang Liu, Nanfang Yao, Zihao Gui, Zimeng Huang, Yi Zeng, Lan Liu, Heng Wan, Jie Shen

    Although studies have focused on the relationship between serum essential elements and muscle mass or muscle strength, research on sex- and age-specific associations between any two of them was limited. The purpose of this study was to investigate the linear and nonlinear relationships between four serum essential elements, including copper (Cu), zinc (Zn), magnesium (Mg), and calcium (Ca), with muscle health, including appendicular skeletal muscle mass (ASM), grip strength and fat-to-muscle ratio (FMR) among Chinese adults, and to explore the differences in these associations according to sex and age. This study included participants aged 18 years or older who completed bioelectrical impedance analysis (BIA) and serological testing. ASM and grip strength were adjusted by dividing by body mass index (BMI). The multivariable linear regression, the subgroup analysis, and the restricted cubic spline (RCS) analysis were carried out. Linear trend tests and interaction tests were also conducted. A total of 5389 community-dwelling adults were included in the study. In the multivariable linear regression, serum Cu was negatively correlated with ASM/BMI and grip strength/BMI (both P for trend < 0.001), while there was a significant positive correlation with FMR (P for trend < 0.001). Inversely, serum Zn was positively correlated with ASM/BMI and grip strength/BMI (both P for trend < 0.001), while there was a significant negative correlation with FMR (P for trend = 0.006). In the subgroup analysis of sex and age, serum Cu showed stronger negative associations with ASM/BMI (P for interaction = 0.001) and grip strength/BMI (P for interaction = 0.004) in younger adults and a stronger positive association with FMR (P for interaction < 0.001) in adult women. In the RCS analysis, a nonlinear and reverse L-shaped association was detected between serum Cu and FMR (P for nonlinear < 0.004), as well as serum Zn and grip strength/BMI (P for nonlinear = 0.043). Elevated serum Cu levels are correlated with diminished muscle health, with variations observed across different age groups and genders. In contrast, increased serum Zn and Ca levels are associated with enhanced muscle health. Maintaining the balance of serum essential elements for preserving muscle health may be worthy of note. However, further research is warranted to validate the conclusions.


  • Open Access

    Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk

    by Zihao Gui, Xingying Chen, Dongmei Wang, Zhi Chen, Siyang Liu, Genfeng Yu, Yuqi Jiang, Hualin Duan, Daoyan Pan, Xu Lin, et al.

    Liver steatosis and fibrosis increase the predicted 10-year atherosclerotic cardiovascular disease (ASCVD) risk, though the roles of chronic inflammation and metabolic dysregulation remain unclear. This cross-sectional study quantitatively assesses this association and evaluates the mediating effects of metabolic dysregulation and chronic inflammation. In this study, we enrolled 6110 adults from ten communities in Canton, China. Hepatic steatosis and fibrosis were assessed using vibration-controlled transient elastography (VCTE) through controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), while predicted 10-year ASCVD risk was calculated using the China-PAR project model. Associations between CAP/LSM values and predicted 10-year ASCVD risk were analyzed. Mediation analysis quantified the effects of high-sensitivity C-reactive protein (hs-CRP), homeostasis model assessment of insulin resistance (HOMA-IR), remnant cholesterol (RC), and non-high-density lipoprotein cholesterol (non-HDL-C). The main statistical methods used included logistic regression, restricted cubic splines (RCS) analysis, interaction calculations, and mediation analysis to examine the relationships and mediators. The study population had a mean age of 50.1 years (SD = 9.7), with 3927 females (64.3%) and 2183 males (35.7%). Additionally, 808 participants (13.2%) had type 2 diabetes, and 1911 participants (31.3%) had hypertension. Compared to the first CAP quartile (Q1), higher CAP quartiles showed increased odds ratios (OR) for predicted moderate to high 10-year ASCVD risk: 1.14 (0.89, 1.45), 1.37 (1.08, 1.73), and 2.44 (1.93, 3.10). Mediation analysis showed hs-CRP and HOMA-IR mediated CAP's link to ASCVD risk, with mediation proportions of 15.40% and 27.37%. RC and non-HDL-C mediated this association at 7.12% and 6.26%. Among patients with hepatic steatosis (CAP ≥ 248 dB/m), LSM Q4 participants had a significantly higher predicted 10-year ASCVD risk than those in LSM Q1 (OR 2.22, [1.52, 3.25]), with hs-CRP and HOMA-IR mediating 2.62% and 13.75%, respectively. Liver steatosis and fibrosis were associated with the increased predicted ASCVD risk, with mediation effects from hs-CRP, HOMA-IR, RC, and non-HDL-C.


  • Open Access

    Domestic water hardness, genetic risk, and distinct phenotypes of cardiovascular disease

    by Feng Tian, Genfeng Yu, Mengyuan Yang, Ying Sun, Zihao Gui, Xiaoyu Zhao, Ningjian Wang, Heng Wan, Xuetao Peng

    The study aimed to investigate the association between domestic water hardness and the incidence of AF and the interaction effects between water hardness and genetic susceptibility to incident AF risk. As a secondary objective, its associations with incident heart failure (HF), coronary heart disease (CHD), and stroke were measured. The UK Biobank is a prospective cohort study comprising over 500,000 participants recruited in the United Kingdom between 2006 and 2010, aged 37 to 73 years. A total of 447,950 participants did not have prevalent AF, and 423,946 participants who were free of HF, CHD, and stroke at baseline were included. Water hardness was assessed by CaCO3 concentration. The genetic risk score for AF was based on the standard polygenic risk score. Cox proportional hazards regression models and restricted cubic spline (RCS) analysis were conducted. During a median follow-up of 13.74 years, 30,726 (6.86%) individuals were diagnosed with AF for the first time. Compared with those with water hardness ≤ 60 mg/L, individuals with domestic water hardness 121–180 mg/L had a 17% lower risk of developing AF (HR 0.83, 95% CI 0.79–0.87), but water hardness of 61-120 mg/L and > 180 mg/L was associated with a higher risk of incident AF (both 1.04, 1.01–1.07). A non-linear relationship between water hardness and incident AF (P for non-linear = 0.001) was found. Individuals with water hardness 121-180 mg/L were also significantly associated with a lower risk of incident HF (HR 0.82, 95% CI 0.75–0.89), CHD (HR 0.80, 95% CI 0.76–0.84) and stroke (HR 0.88, 95% CI 0.81–0.95). There were no significant interaction effects between water hardness level and genetic susceptibility to AF, HF, CHD, and stroke risk (all P for interaction > 0.05). Potential U-shaped associations between domestic water hardness and incident AF across varying levels of genetic risk were found. Hard water (121–180 mg/L) may offer the most benefits compared to soft water when considering overall cardiovascular health, including AF, HF, CHD, and stroke.